Skip to main content

Invivyd, Inc 8-K, filed Nov 16, 2026

Invivyd, Inc. (IVVD)

8-K 2026-11-16 For: 2026-11-16
View Original
Added on November 16, 2026

About this 8-K

Invivyd, Inc filed this 8-K on November 16, 2026.

Invivyd said DECLARATION interim analysis data are expected imminently after discussions with the FDA. Q3 2026 PEMGARDA net product revenue rose 18% to $15.4 million, cash and cash equivalents were $126.4 million, and net loss was $33.5 million. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits